Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Journal of Neuroimmunology|February 18, 2019
IVIG efficacy in CIDP patients is not associated with terminal complement inhibitionChristian W Keller, Isaak Quast, Marinos C Dalakas, et al.Neurology(R) Neuroimmunology & Neuroinflammation|September 18, 2015
Deregulated Fcγ receptor expression in patients with CIDPIsaak Quast, Flavio Cueni, Falk Nimmerjahn, et al.Clinical & Translational Immunology|April 15, 2024
Chimeric antigen receptor T cells in the fast lane among autoimmune disease therapiesZhoujie Ding, David TarlintonFrontiers in Immunology|June 22, 2017
Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent CytotoxicityBenjamin Peschke, Christian W Keller, Patrick Weber, et al.Annals of Clinical and Translational Neurology|September 21, 2016
Terminal complement activation is increased and associated with disease severity in CIDPIsaak Quast, Christian W Keller, Falk Hiepe, et al.Science (New York, N.Y.)|September 14, 2013
Diversity among memory B cells: origin, consequences, and utilityDavid Tarlinton, Kim Good-JacobsonTrends in Molecular Medicine|November 28, 2016
HIV Vaccines: One Step CloserMichael Sze Yuan Low, David TarlintonJournal of Neuroinflammation|February 20, 2016
Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammationIsaak Quast, Christian W Keller, Patrick Weber, et al.Cell Reports|February 6, 2020
The Amount of BCL6 in B Cells Shortly after Antigen Engagement Determines Their Representation in Subsequent Germinal CentersMarcus James Robinson, Zhoujie Ding, Catherine Pitt, et al.Pageof 7